SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001159036-21-000003
Filing Date
2021-01-11
Accepted
2021-01-11 08:07:26
Documents
16
Period of Report
2021-01-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K halo-20210111.htm   iXBRL 8-K 41187
2 EX-99.1 ex991halo2021guidance.htm EX-99.1 25472
8 image_01.jpg GRAPHIC 17587
  Complete submission text file 0001159036-21-000003.txt   238769

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20210111.xsd EX-101.SCH 2436
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20210111_cal.xml EX-101.CAL 722
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20210111_def.xml EX-101.DEF 1659
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20210111_lab.xml EX-101.LAB 24275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20210111_pre.xml EX-101.PRE 12658
9 EXTRACTED XBRL INSTANCE DOCUMENT halo-20210111_htm.xml XML 10772
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 21519337
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences